Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,695.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 10.00 (0.15%)
Market Cap: £4.94b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Director/PDMR Shareholding

14 May 2026 10:39

RNS Number : 3607E
Spirax Group PLC
14 May 2026
 

 

14 May 2026

Award of Shares to Persons Discharging Management Responsibilities ("PDMRs") of Spirax Group plc (the "Company")

 

Further to the announcement made on 26 March 2026 regarding awards granted under the Company's 2023 Performance Share Plan ("2023 PSP"), the Company confirms that, following shareholder approval at the Company's 2026 Annual General Meeting of the updated Remuneration Policy and the Company's Share Award Plan Rules, (Share Rules) the following additional awards have been approved.

As disclosed in the Company's 2025 Annual Report and Accounts, Nimesh Patel, Group Chief Executive Officer, was awarded a Performance Share Plan ("PSP") award for the 2026 grant cycle in two parts.

In March 2026, an initial award equivalent to 250% of base salary was granted in accordance with the Company's existing Remuneration Policy. The remaining part of the award was subject to shareholder approval of the new Remuneration Policy and the Share Rules, which has now been obtained at the Company's 2026 Annual General Meeting on 13 May 2026.

Following that approval, the Remuneration Committee has granted the second part of Nimesh Patel's 2026 PSP award of 6,193 shares. Consistent with the disclosure in the Company's Annual Report 2025, this award has been granted using the same March 2026 grant price, and on the same performance conditions and vesting timetable as the initial March 2026 award.

Further to the disclosure in the 2025 Directors' Remuneration Report, the Company confirms that an additional award has been approved for Louisa Burdett, Group Chief Financial Officer.

An administrative error resulted in Louisa's March 2025 PSP award being calculated at 125% of her 2025 base salary, rather than the intended 175%, as disclosed in the Annual Report 2024. To correct this error, a further award in respect of the shortfall of 4,171 shares has been granted today, on the same terms and conditions as the original March 2025 PSP award.

The awards described above will vest subject to the achievement of the applicable performance conditions over the relevant performance periods and are subject to the post‑vesting holding requirements set out in the Remuneration Policy.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nimesh Patel

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Spirax Group plc

b)

 

LEI

 

 

213800WFVZQMHOZP2W17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

2612/13p Ordinary Shares

Identification code

ISIN: GB00BWFGQN14

b)

 

Nature of the transaction

 

A conditional award of ordinary shares in the Company's 2023 PSP. 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£65.67

6,193

d)

 

Aggregated information

- Aggregated volume

6,193

- Aggregated Price per share

£65.67

e)

 

Date of the transaction

 

 

14 May 2026

f)

 

Place of the transaction

 

 

Outside a trading venue

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Louisa Burdett

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Spirax Group plc

b)

 

LEI

 

213800WFVZQMHOZP2W17

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

2612/13p Ordinary Shares

Identification code

ISIN: GB00BWFGQN14

b)

 

Nature of the transaction

 

 

A conditional award of ordinary shares in the Company's 2023 PSP.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£71.92

4,171

d)

 

Aggregated information

- Aggregated volume

4,171

- Aggregated Price per share

£71.92

e)

 

Date of the transaction

 

 

14 May 2026

f)

 

Place of the transaction

 

 

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKQBNCBKKOPD
Date   Source Headline
21st Nov 20173:08 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTrading Statement
14th Nov 201710:39 amRNSDirector/PDMR Shareholding
16th Oct 20175:35 pmRNSDirector/PDMR Shareholding
29th Sep 20173:36 pmRNSHolding(s) in Company
9th Aug 20177:00 amRNSHalf-year Report
4th Jul 20177:00 amRNSCompletion of Acquisition
23rd Jun 20179:11 amRNSTotal Voting Rights
20th Jun 20173:59 pmRNSHolding(s) in Company
12th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20179:08 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSAcquisition of Chromalox for US$415 million
9th May 20174:30 pmRNSResult of AGM
9th May 20177:00 amRNSTrading Statement
4th May 20174:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Acquisition
26th Apr 20178:42 amRNSHolding(s) in Company
25th Apr 20179:10 amRNSHolding(s) in Company
19th Apr 20173:55 pmRNSHolding(s) in Company
18th Apr 20173:58 pmRNSHolding(s) in Company
3rd Apr 20177:30 amRNSAcquisition
24th Mar 20174:44 pmRNSTotal Voting Rights
23rd Mar 20171:45 pmRNSDirector/PDMR Shareholding
17th Mar 20174:04 pmRNSDirector/PDMR Shareholding
9th Mar 20177:00 amRNSFinal Results
30th Nov 20167:00 amRNSAcquisition
22nd Nov 20167:00 amRNSTrading Statement
17th Nov 20164:23 pmRNSDirector/PDMR Shareholding
14th Nov 20168:30 amRNSDr Krishnamurthy Rajagopal
10th Nov 201611:40 amRNSListing Application
8th Nov 201611:57 amRNSChange of Director Details
4th Nov 20164:27 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSBoard Succession Changes
17th Oct 20162:49 pmRNSAdditional Listing
14th Oct 20165:03 pmRNSDirector/PDMR Shareholding
14th Oct 20163:20 pmRNSTotal Voting Rights
14th Oct 20163:17 pmRNSBlock listing Interim Review
6th Oct 201611:48 amRNSNotification of Release Date - Trading Statement
8th Sep 201612:44 pmRNSTotal Voting Rights
18th Aug 20168:30 amRNSBoard Appointment
12th Aug 20163:51 pmRNSDirector/PDMR Shareholding
9th Aug 20167:05 amRNSSpirax Sarco acquires assets of Hiter for £3.9 m
9th Aug 20167:00 amRNS2016 Half Year Results
5th Aug 20162:56 pmRNSTotal Voting Rights
1st Jul 201611:43 amRNSTotal Voting Rights
29th Jun 20169:29 amRNSNotice of Results
21st Jun 20165:40 pmRNSDirector/PDMR Shareholding
10th Jun 20162:59 pmRNSHolding(s) in Company
2nd Jun 20164:20 pmRNSAdditional Listing
2nd Jun 20163:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.